Paul Tudor Jones Ionis Pharmaceuticals Inc Call Options Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
Call Options
2 transactions
Others Institutions Holding IONS
# of Institutions
401Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$549 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$542 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$414 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$346 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$282 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.76B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...